YOUR BUSINESS AUTHORITY
Springfield, MO
Danish drugmaker Novo Nordisk's parent company, Novo Holdings, has signed on for a $16.5 billion acquisition.
The company is buying drug manufacturer Catalent.
CNBC reports the deal could help shore up the supply of weight loss injection Wegovy and diabetes shot Ozempic.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach